Vaxcyte shareholders re-elect three Class III directors at annual meeting

• Vaxcyte held its annual shareholder meeting on June 15, 2026.
• Shareholders backed the appointment of Deloitte & Touche as independent auditor for fiscal 2026; the vote ratified the appointment.
• Shareholders also adopted a non-binding advisory resolution on named executive officer pay.
• The filing did not indicate any operational changes resulting from the advisory vote.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001649094-26-000021), on June 16, 2026, and is solely responsible for the information contained therein.